drugset / Trial / NCT00904423
Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
NaSingle-groupOpen-labelTreatment
Summary
Aromatase inhibitors are potent suppressors of breast cancer growth, but side effects include bone loss, fractures, arthralgias and myalgias. We hypothesize vitamin D administration might be beneficial in treating these symptoms and to protect bone.
Timeline
- Start
- 2009-04
- Primary completion
- 2011-04
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin D | Other / unclassified | 2400 mg | Oral |